214 related articles for article (PubMed ID: 24801563)
1. Effect of metformin on the incidence of head and neck cancer in diabetics.
Yen YC; Lin C; Lin SW; Lin YS; Weng SF
Head Neck; 2015 Sep; 37(9):1268-73. PubMed ID: 24801563
[TBL] [Abstract][Full Text] [Related]
2. Risk of head and neck cancer in patients with diabetes mellitus: a retrospective cohort study in Taiwan.
Tseng KS; Lin C; Lin YS; Weng SF
JAMA Otolaryngol Head Neck Surg; 2014 Aug; 140(8):746-53. PubMed ID: 25058016
[TBL] [Abstract][Full Text] [Related]
3. The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer.
Yung KC; Piccirillo JF
Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1045-9. PubMed ID: 18936348
[TBL] [Abstract][Full Text] [Related]
4. Insulin use increases risk of asthma but metformin use reduces the risk in patients with diabetes in a Taiwanese population cohort.
Chen CZ; Hsu CH; Li CY; Hsiue TR
J Asthma; 2017 Dec; 54(10):1019-1025. PubMed ID: 28135899
[TBL] [Abstract][Full Text] [Related]
5. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.
Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Babjuk M; Bachmann A; Scherr DS; Shariat SF
Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245
[TBL] [Abstract][Full Text] [Related]
6. Survival impact and toxicity of metformin in head and neck cancer: An analysis of the SEER-Medicare dataset.
Stokes WA; Eguchi M; Amini A; Hararah MK; Ding D; McDermott JD; Bradley CJ; Karam SD
Oral Oncol; 2018 Sep; 84():12-19. PubMed ID: 30115470
[TBL] [Abstract][Full Text] [Related]
7. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.
Kowall B; Stang A; Rathmann W; Kostev K
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313
[TBL] [Abstract][Full Text] [Related]
8. Diabetes mellitus, metformin and head and neck cancer.
Figueiredo RA; Weiderpass E; Tajara EH; Ström P; Carvalho AL; de Carvalho MB; Kanda JL; Moyses RA; Wünsch-Filho V
Oral Oncol; 2016 Oct; 61():47-54. PubMed ID: 27688104
[TBL] [Abstract][Full Text] [Related]
9. Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer.
Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Fajkovic H; Babjuk M; Kautzky-Willer A; Bachmann A; Scherr DS; Shariat SF
BJU Int; 2013 Dec; 112(8):1105-12. PubMed ID: 24053906
[TBL] [Abstract][Full Text] [Related]
10. Comorbidity and prognosis in head and neck cancers: Differences by subsite, stage, and human papillomavirus status.
Habbous S; Harland LT; La Delfa A; Fadhel E; Xu W; Liu FF; Goldstein D; Waldron J; Huang SH; O'Sullivan B; Liu G
Head Neck; 2014 Jun; 36(6):802-10. PubMed ID: 23616414
[TBL] [Abstract][Full Text] [Related]
11. Oral hypoglycaemic agents and the development of non-fatal cardiovascular events in patients with type 2 diabetes mellitus.
Hung YC; Lin CC; Wang TY; Chang MP; Sung FC; Chen CC
Diabetes Metab Res Rev; 2013 Nov; 29(8):673-9. PubMed ID: 23956007
[TBL] [Abstract][Full Text] [Related]
12. Metformin use and prostate cancer risk.
Preston MA; Riis AH; Ehrenstein V; Breau RH; Batista JL; Olumi AF; Mucci LA; Adami HO; Sørensen HT
Eur Urol; 2014 Dec; 66(6):1012-20. PubMed ID: 24857538
[TBL] [Abstract][Full Text] [Related]
13. The Influence of Diabetes Mellitus and Metformin on Distant Metastases in Oropharyngeal Cancer: A Multicenter Study.
Spratt DE; Beadle BM; Zumsteg ZS; Rivera A; Skinner HD; Osborne JR; Garden AS; Lee NY
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):523-531. PubMed ID: 26867881
[TBL] [Abstract][Full Text] [Related]
14. Metformin-inclusive therapy reduces the risk of stroke in patients with diabetes: a 4-year follow-up study.
Cheng YY; Leu HB; Chen TJ; Chen CL; Kuo CH; Lee SD; Kao CL
J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):e99-105. PubMed ID: 24119365
[TBL] [Abstract][Full Text] [Related]
15. The effect of diabetes and metformin on clinical outcomes is negligible in risk-adjusted endometrial cancer cohorts.
Al Hilli MM; Bakkum-Gamez JN; Mariani A; Cliby WA; Mc Gree ME; Weaver AL; Dowdy SC; Podratz KC
Gynecol Oncol; 2016 Feb; 140(2):270-6. PubMed ID: 26607780
[TBL] [Abstract][Full Text] [Related]
16. Antidiabetes drugs correlate with decreased risk of lung cancer: a population-based observation in Taiwan.
Lai SW; Liao KF; Chen PC; Tsai PY; Hsieh DP; Chen CC
Clin Lung Cancer; 2012 Mar; 13(2):143-8. PubMed ID: 22129971
[TBL] [Abstract][Full Text] [Related]
17. Effect of pioglitazone medication on the incidence of dementia.
Heneka MT; Fink A; Doblhammer G
Ann Neurol; 2015 Aug; 78(2):284-94. PubMed ID: 25974006
[TBL] [Abstract][Full Text] [Related]
18. Increased risk of urinary tract calculi among patients with diabetes mellitus--a population-based cohort study.
Chen HS; Su LT; Lin SZ; Sung FC; Ko MC; Li CY
Urology; 2012 Jan; 79(1):86-92. PubMed ID: 22119251
[TBL] [Abstract][Full Text] [Related]
19. Metformin may reduce bladder cancer risk in Taiwanese patients with type 2 diabetes.
Tseng CH
Acta Diabetol; 2014 Apr; 51(2):295-303. PubMed ID: 24509842
[TBL] [Abstract][Full Text] [Related]
20. Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus.
Tseng CH
Eur J Cancer; 2014 Nov; 50(16):2831-7. PubMed ID: 25201464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]